These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5378103)

  • 1. Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid.
    Miettinen TA; Taskinen MR; Pelkonen R; Nikkilä EA
    Acta Med Scand; 1969 Oct; 186(4):247-53. PubMed ID: 5378103
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral glucose tolerance, plasma insulin, and uric acid excretion in man during chronic administration of nicotinic acid.
    Gaut ZN; Pocelinko R; Solomon HM; Thomas GB
    Metabolism; 1971 Nov; 20(11):1031-5. PubMed ID: 5115752
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of nicotinic acid on the rates of turnover and oxidation of plasma glucose in man.
    Balasse EO; Neef MA
    Metabolism; 1973 Sep; 22(9):1193-204. PubMed ID: 4726369
    [No Abstract]   [Full Text] [Related]  

  • 4. Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis.
    Schlierf G; Dorow E
    J Clin Invest; 1973 Mar; 52(3):732-40. PubMed ID: 4685092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of nicotinic acid on growth hormone-induced lipolysis and glucose intolerance.
    Davidson MB; Bernstein JM
    J Lab Clin Med; 1973 Apr; 81(4):568-76. PubMed ID: 4696189
    [No Abstract]   [Full Text] [Related]  

  • 6. [Mode of action of blood glucose lowering biguanides: clinical aspects].
    Mehnert H
    Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():678-84. PubMed ID: 4906985
    [No Abstract]   [Full Text] [Related]  

  • 7. [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)].
    Bottermann P; Schweigart U; Ermler R
    Med Klin; 1976 Sep; 71(36):1423-8. PubMed ID: 958105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carbohydrate metabolism in liver cirrhosis. I. Glucose tolerance disorders].
    Smoczyński M
    Pol Arch Med Wewn; 1975 Nov; 54(5):435-43. PubMed ID: 1197057
    [No Abstract]   [Full Text] [Related]  

  • 9. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of administration of nicotinic acid on glucose, insulin, and glucose tolerance in ruminants.
    Thornton JH; Schultz LH
    J Dairy Sci; 1980 Feb; 63(2):262-8. PubMed ID: 6987284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of butylbiguanide during long lasting intravenous glucose infusion in normal human subjects.
    Gomez F; Felber JP
    Horm Metab Res; 1970 Mar; 2(2):72-5. PubMed ID: 5520911
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
    Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
    Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in carbohydrate metabolism in liver cirrhosis during glucose infusion tests].
    Rogos R; Meisel B; Erler K
    Z Gesamte Inn Med; 1982 Apr; 37(8):228-32. PubMed ID: 7051589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the behavior of carbohydrates and immunoreactive insulin in hepatic cirrhosis].
    Savastano A; Rocca F; Lodi G; Gobbi A
    Minerva Med; 1975 Nov; 66(80):4235-41. PubMed ID: 1196517
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anomalies of glycoregulation in alcoholic cirrhosis of the liver].
    Charbonnel B; Murat A; Du Rostu H; Schneebeli S; Guillon J
    Journ Annu Diabetol Hotel Dieu; 1984; ():125-36. PubMed ID: 6399528
    [No Abstract]   [Full Text] [Related]  

  • 16. [Causes of the blood sugar decreasing effect of biguanides].
    Berger W
    Schweiz Rundsch Med Prax; 1970 Aug; 59(34):1203-6. PubMed ID: 5513428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of dimethylbiguanide on glucose tolerance and on betapancreatic function in obese children with normal glucose tolerance].
    Pelti M; Del Guercio MJ; Caccamo A; Garlaschi C; Di Natale B; Episcopi ME; Moreno A
    Minerva Pediatr; 1974 Sep; 26(27):1340-4. PubMed ID: 4617151
    [No Abstract]   [Full Text] [Related]  

  • 18. [Glucose-lactic acid metabolism during clinical use of biguanides].
    Pedersen J
    Ugeskr Laeger; 1973 Jul; 135(31):1632-5. PubMed ID: 4585752
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of diet composition on insulin output, carbohydrate tolerance and lipid values in primary hypertriglyceridemia (HT).
    Julius U; Schulze J; Schollberg K; Leonhardt W; Hanefeld M; Zschornack M; Haller H
    Endokrinologie; 1978 Mar; 71(3):299-307. PubMed ID: 688979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of triglyceridemia level on glucose tolerance and insulinemia in subjects with type IV hyperlipoproteinemia.
    Debry G; Drouin P; Mejean L
    Horm Metab Res; 1974 Sep; 6(5):421-2. PubMed ID: 4425070
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.